Agarwal S et al (2020) PAICS, a De Novo purine biosynthetic enzyme, is overexpressed in pancreatic cancer and is involved in its progression. Transl Oncol 13(7):100776

Article  PubMed Central  Google Scholar 

Ahmed MB et al (2022) cAMP signaling in cancer: a PKA-CREB and EPAC-centric approach. Cells 11(13):2020

Article  CAS  PubMed Central  Google Scholar 

Bai Q et al (2022) Metastatic tumor cell-specific FABP7 promotes NSCLC metastasis via inhibiting beta-catenin degradation. Cells 11(5):805

Article  CAS  PubMed Central  Google Scholar 

Barzaman K et al (2020) Breast cancer: Biology, biomarkers, and treatments. Int Immunopharmacol 84:106535

Article  CAS  Google Scholar 

Benatzy Y, Palmer MA, Brune B (2022) Arachidonate 15-lipoxygenase type B: regulation, function, and its role in pathophysiology. Front Pharmacol 13:1042420

Article  CAS  PubMed Central  Google Scholar 

Chang NW et al (2013) High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation. J Nutr Biochem 24(1):274–281

Article  CAS  Google Scholar 

Chang J et al (2023) Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma. J Transl Med 21(1):191

Article  CAS  PubMed Central  Google Scholar 

Charoentong P et al (2017) Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep 18(1):248–262

Article  CAS  Google Scholar 

Dalva M et al (2017) Copy number variants and VNTR length polymorphisms of the carboxyl-ester lipase (CEL) gene as risk factors in pancreatic cancer. Pancreatology 17(1):83–88

Article  CAS  Google Scholar 

Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364–378

Article  CAS  PubMed Central  Google Scholar 

Desai P, Aggarwal A (2021) Breast cancer in women over 65 years- a review of screening and treatment options. Clin Geriatr Med 37(4):611–623

Article  Google Scholar 

Dong H et al (2015) Inhibition of breast cancer cell migration by activation of cAMP signaling. Breast Cancer Res Treat 152(1):17–28

Article  CAS  Google Scholar 

Du B et al (2021) PAICS is related to glioma grade and can promote glioma growth and migration. J Cell Mol Med 25(16):7720–7733

Article  CAS  PubMed Central  Google Scholar 

Garufi C et al (2001) Single-agent oxaliplatin in pretreated advanced breast cancer patients: a phase II study. Ann Oncol 12(2):179–182

Article  CAS  Google Scholar 

Giaquinto AN et al (2022) Breast cancer statistics, 2022. CA Cancer J Clin 72(6):524–541

Article  Google Scholar 

Gombos A, Awada A (2017) Advances in chemical pharmacotherapy to manage advanced breast cancer. Expert Opin Pharmacother 18(1):95–103

Article  CAS  Google Scholar 

Grasso D et al (2020) Mitochondria in cancer. Cell Stress 4(6):114–146

Article  CAS  PubMed Central  Google Scholar 

Harbeck N, Gnant M (2017) Breast cancer. Lancet 389(10074):1134–1150

Article  Google Scholar 

Huang J et al (2021) MTHFD2 facilitates breast cancer cell proliferation via the AKT signaling pathway. Exp Ther Med 22(1):703

Article  CAS  PubMed Central  Google Scholar 

Ihle CL, Wright-Hobart SJ, Owens P (2022) Therapeutics targeting the metastatic breast cancer bone microenvironment. Pharmacol Ther 239:108280

Article  CAS  Google Scholar 

Jeong D et al (2021) ELOVL2: a novel tumor suppressor attenuating tamoxifen resistance in breast cancer. Am J Cancer Res 11(6):2568–2589

CAS  PubMed Central  Google Scholar 

Jeschke J et al (2017) DNA methylation-based immune response signature improves patient diagnosis in multiple cancers. J Clin Invest 127(8):3090–3102

Article  PubMed Central  Google Scholar 

Jiang P et al (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24(10):1550–1558

Article  CAS  PubMed Central  Google Scholar 

Johansson BB et al (2018) The role of the carboxyl ester lipase (CEL) gene in pancreatic disease. Pancreatology 18(1):12–19

Article  CAS  Google Scholar 

Kagawa Y et al (2019) Role of FABP7 in tumor cell signaling. Adv Biol Regul 71:206–218

Article  CAS  Google Scholar 

Kawiak A (2022) Molecular research and treatment of breast cancer. Int J Mol Sci 23(17):9617

Article  PubMed Central  Google Scholar 

Kciuk M, Marciniak B, Kontek R (2020) Irinotecan-still an important player in cancer chemotherapy: a comprehensive overview. Int J Mol Sci 21(14):4919

Article  CAS  PubMed Central  Google Scholar 

Kittler R et al (2013) A comprehensive nuclear receptor network for breast cancer cells. Cell Rep 3(2):538–551

Article  CAS  Google Scholar 

Kopinski PK et al (2021) Mitochondrial DNA variation and cancer. Nat Rev Cancer 21(7):431–445

Article  CAS  Google Scholar 

Kulkarni S et al (2008) COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situ. BMC Cancer 8:36

Article  PubMed Central  Google Scholar 

Lapatinib, in LiverTox: clinical and research information on drug-induced liver injury (2012) Bethesda (MD)

Le L et al (2023) 5-Azacytidine promotes HCC cell metastasis by up-regulating RDH16 expression. Eur J Pharmacol 950:175736

Article  CAS  Google Scholar 

Lin CH et al (2021) High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia. NPJ Breast Cancer 7(1):88

Article  CAS  PubMed Central  Google Scholar 

Liu ZH et al (2020) ZIC2 is downregulated and represses tumor growth via the regulation of STAT3 in breast cancer. Int J Cancer 147(2):505–518

Article  CAS  Google Scholar 

Liu X et al (2021a) PRRC2A promotes hepatocellular carcinoma progression and associates with immune infiltration. J Hepatocell Carcinoma 8:1495–1511

Article  CAS  PubMed Central  Google Scholar 

Liu H et al (2021b) Metabolic molecule PLA2G2D is a potential prognostic biomarker correlating with immune cell infiltration and the expression of immune checkpoint genes in cervical squamous cell carcinoma. Front Oncol 11:755668

Article  CAS  PubMed Central  Google Scholar 

Lu J, Tan M, Cai Q (2015) The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett 356(2 Pt A):156–64

Article  CAS  Google Scholar 

Mao YS et al (2020) Epidemiological characteristic and current status of surgical treatment for esophageal cancer by analysis of national registry database. Zhonghua Zhong Liu Za Zhi 42(3):228–233

CAS  Google Scholar 

Meng M et al (2018) Knockdown of PAICS inhibits malignant proliferation of human breast cancer cell lines. Biol Res 51(1):24

Article  PubMed Central  Google Scholar 

Meng C, Sun Y, Liu G (2023) Establishment of a prognostic model for ovarian cancer based on mitochondrial metabolism-related genes. Front Oncol 13:1144430

Article  CAS  PubMed Central  Google Scholar 

Merino Bonilla JA, Torres Tabanera M, Ros Mendoza LH (2017) Breast cancer in the 21st century: from early detection to new therapies. Radiologia 59(5):368–379

Article  CAS  Google Scholar 

Niu M et al (2021) DCTPP1, an oncogene regulated by miR-378a-3p, promotes proliferation of breast cancer via DNA repair signaling pathway. Front Oncol 11:641931

Article  CAS  PubMed Central  Google Scholar 

Oh DY, Bang YJ (2020) HER2-targeted therapies—a role beyond breast cancer. Nat Rev Clin Oncol 17(1):33–48

Article  CAS  Google Scholar 

Patergnani S et al (2020) Various aspects of calcium signaling in the regulation of apoptosis, autophagy, cell proliferation, and cancer. Int J Mol Sci 21(21):8323

Article  CAS  PubMed Central  Google Scholar 

Pizzolato JF, Saltz LB (2003) The camptothecins. Lancet 361(9376):2235–2242

Article  CAS  Google Scholar 

Qiu P et al (2021) Characterization of exosome-related gene risk model to evaluate the tumor immune microenvironment and predict prognosis in triple-negative breast cancer. Front Immunol 12:736030

Article  CAS